By the end of 2015, no fewer than four independent laboratories delivered CRISPR to fully grown mice suffering from muscular dystrophy and showed that the ravages of the disease could be reversed. By packaging genetic instructions for CRISPR into AAV vectors, the researchers repaired skeletal and cardiac muscle cells, either by injecting the loaded viruses into the mouse’s muscles or by delivering the viruses to the same tissues through the bloodstream.
